Date Log
Submitted
July 4, 2022
Published
July 4, 2022
The polycystic ovarian syndrome (PCOD) affecting quality of life
International Journal of Allied Medical Sciences and Clinical Research,
Vol. 10 No. 2 (2022): 2022 Volume - 10 Issue - 2
Abstract
Background
The polycystic ovarian syndrome (PCOD) is the most common endocrine disorder. PCOS-related problems such as infertility, subfertility, hirsutism and oligo/amenorrhea may lead to significant reduction in a woman’s quality of life and her self-perception of body shape.
Methodology
A study was carried out in which 35 females dignosed with PCOS were given the PCOSQ to asses the quality of life.
Results and Conclusion
In this study we concluded that Quality of life was affected in females with PCOS.
The polycystic ovarian syndrome (PCOD) is the most common endocrine disorder. PCOS-related problems such as infertility, subfertility, hirsutism and oligo/amenorrhea may lead to significant reduction in a woman’s quality of life and her self-perception of body shape.
Methodology
A study was carried out in which 35 females dignosed with PCOS were given the PCOSQ to asses the quality of life.
Results and Conclusion
In this study we concluded that Quality of life was affected in females with PCOS.
Keywords
polycystic ovarian syndrome, QOL
Radhika S. Rathi, Pournima Pawar, & Rasika Pawer. (2022). The polycystic ovarian syndrome (PCOD) affecting quality of life. International Journal of Allied Medical Sciences and Clinical Research, 10(2), 255–260. https://doi.org/10.61096/ijamscr.v10.iss2.2022.255-260
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX
References
-
1. Prathap A, Subhalakshmi TP, Varghese PJ.. A Cross-sectional Study on the Proportion of Anxiety and Depression and Determinants of Quality of Life in Polycystic Ovarian Disease. Indian J Psychol Med. 2018 May-Jun; 40(3): 257–262. doi: 10.4103/IJPSYM.IJPSYM_221_17
2. McGowan MP. Polycystic ovary syndrome: a common endocrine disorder and risk factor for vascular disease. Curr Treat Options Cardiovasc Med. 2011 Aug;13(4):289-301. doi: 10.1007/s11936-011-0130-0. PMID: 21562798.
3. L. Barnard, D. Ferriday, N. Guenther, B. Strauss, A.H. Balen, L. Dye, Quality of life and psychological well being in polycystic ovary syndrome, Human Reproduction, Volume 22, Issue 8, August 2007, Pages 2279–2286, https://doi.org/10.1093/humrep/dem108
4. Brady C, Mousa SS, Mousa SA. Polycystic ovary syndrome and its impact on women's quality of life: More than just an endocrine disorder. Drug Healthc Patient Saf. 2009;1:9-15. doi: 10.2147/dhps.s4388. Epub 2009 Feb 3. PMID: 21701605; PMCID: PMC3108690.
5. Welt CK, Carmina E. Clinical review: Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause. J Clin Endocrinol Metab. 2013 Dec;98(12):4629-38. doi: 10.1210/jc.2013-2375. Epub 2013 Sep 24. PMID: 24064685; PMCID: PMC3849665.
6. Rosenfield RL, Ehrmann DA. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocr Rev. 2016 Oct;37(5):467-520. doi: 10.1210/er.2015-1104. Epub 2016 Jul 26. PMID: 27459230; PMCID: PMC5045492.
7. Alghadeer S, Algarawi A, Abu-Rkybah F, Alshebly MM, Alruthia Y. The translation and validation of the Arabic Version of the Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire (AR-PCOSQ). BMC Womens Health. 2020 Oct 29;20(1):244. doi: 10.1186/s12905-020-01108-0. PMID: 33121466; PMCID: PMC7596927.
8. Sam S. Obesity and Polycystic Ovary Syndrome. Obes Manag. 2007 Apr;3(2):69-73. doi: 10.1089/obe.2007.0019. PMID: 20436797; PMCID: PMC2861983.
9. Gill H, Tiwari P, Dabadghao P. Prevalence of polycystic ovary syndrome in young women from North India: A Community-based study. Indian J Endocrinol Metab. 2012 Dec;16(Suppl 2):S389-92. doi: 10.4103/2230-8210.104104. Erratum in: Indian J Endocrinol Metab. 2013 Jan;17(1):162. PMID: 23565440; PMCID: PMC3603088.
10. Khomami MB, Tehrani FR, Hashemi S, Farahmand M, Azizi F. Of PCOS symptoms, hirsutism has the most significant impact on the quality of life of Iranian women. PLoS One. 2015 Apr 15;10(4):e0123608. doi: 10.1371/journal.pone.0123608. PMID: 25874409; PMCID: PMC4398498.
References
1. Prathap A, Subhalakshmi TP, Varghese PJ.. A Cross-sectional Study on the Proportion of Anxiety and Depression and Determinants of Quality of Life in Polycystic Ovarian Disease. Indian J Psychol Med. 2018 May-Jun; 40(3): 257–262. doi: 10.4103/IJPSYM.IJPSYM_221_17
2. McGowan MP. Polycystic ovary syndrome: a common endocrine disorder and risk factor for vascular disease. Curr Treat Options Cardiovasc Med. 2011 Aug;13(4):289-301. doi: 10.1007/s11936-011-0130-0. PMID: 21562798.
3. L. Barnard, D. Ferriday, N. Guenther, B. Strauss, A.H. Balen, L. Dye, Quality of life and psychological well being in polycystic ovary syndrome, Human Reproduction, Volume 22, Issue 8, August 2007, Pages 2279–2286, https://doi.org/10.1093/humrep/dem108
4. Brady C, Mousa SS, Mousa SA. Polycystic ovary syndrome and its impact on women's quality of life: More than just an endocrine disorder. Drug Healthc Patient Saf. 2009;1:9-15. doi: 10.2147/dhps.s4388. Epub 2009 Feb 3. PMID: 21701605; PMCID: PMC3108690.
5. Welt CK, Carmina E. Clinical review: Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause. J Clin Endocrinol Metab. 2013 Dec;98(12):4629-38. doi: 10.1210/jc.2013-2375. Epub 2013 Sep 24. PMID: 24064685; PMCID: PMC3849665.
6. Rosenfield RL, Ehrmann DA. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocr Rev. 2016 Oct;37(5):467-520. doi: 10.1210/er.2015-1104. Epub 2016 Jul 26. PMID: 27459230; PMCID: PMC5045492.
7. Alghadeer S, Algarawi A, Abu-Rkybah F, Alshebly MM, Alruthia Y. The translation and validation of the Arabic Version of the Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire (AR-PCOSQ). BMC Womens Health. 2020 Oct 29;20(1):244. doi: 10.1186/s12905-020-01108-0. PMID: 33121466; PMCID: PMC7596927.
8. Sam S. Obesity and Polycystic Ovary Syndrome. Obes Manag. 2007 Apr;3(2):69-73. doi: 10.1089/obe.2007.0019. PMID: 20436797; PMCID: PMC2861983.
9. Gill H, Tiwari P, Dabadghao P. Prevalence of polycystic ovary syndrome in young women from North India: A Community-based study. Indian J Endocrinol Metab. 2012 Dec;16(Suppl 2):S389-92. doi: 10.4103/2230-8210.104104. Erratum in: Indian J Endocrinol Metab. 2013 Jan;17(1):162. PMID: 23565440; PMCID: PMC3603088.
10. Khomami MB, Tehrani FR, Hashemi S, Farahmand M, Azizi F. Of PCOS symptoms, hirsutism has the most significant impact on the quality of life of Iranian women. PLoS One. 2015 Apr 15;10(4):e0123608. doi: 10.1371/journal.pone.0123608. PMID: 25874409; PMCID: PMC4398498.
2. McGowan MP. Polycystic ovary syndrome: a common endocrine disorder and risk factor for vascular disease. Curr Treat Options Cardiovasc Med. 2011 Aug;13(4):289-301. doi: 10.1007/s11936-011-0130-0. PMID: 21562798.
3. L. Barnard, D. Ferriday, N. Guenther, B. Strauss, A.H. Balen, L. Dye, Quality of life and psychological well being in polycystic ovary syndrome, Human Reproduction, Volume 22, Issue 8, August 2007, Pages 2279–2286, https://doi.org/10.1093/humrep/dem108
4. Brady C, Mousa SS, Mousa SA. Polycystic ovary syndrome and its impact on women's quality of life: More than just an endocrine disorder. Drug Healthc Patient Saf. 2009;1:9-15. doi: 10.2147/dhps.s4388. Epub 2009 Feb 3. PMID: 21701605; PMCID: PMC3108690.
5. Welt CK, Carmina E. Clinical review: Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause. J Clin Endocrinol Metab. 2013 Dec;98(12):4629-38. doi: 10.1210/jc.2013-2375. Epub 2013 Sep 24. PMID: 24064685; PMCID: PMC3849665.
6. Rosenfield RL, Ehrmann DA. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocr Rev. 2016 Oct;37(5):467-520. doi: 10.1210/er.2015-1104. Epub 2016 Jul 26. PMID: 27459230; PMCID: PMC5045492.
7. Alghadeer S, Algarawi A, Abu-Rkybah F, Alshebly MM, Alruthia Y. The translation and validation of the Arabic Version of the Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire (AR-PCOSQ). BMC Womens Health. 2020 Oct 29;20(1):244. doi: 10.1186/s12905-020-01108-0. PMID: 33121466; PMCID: PMC7596927.
8. Sam S. Obesity and Polycystic Ovary Syndrome. Obes Manag. 2007 Apr;3(2):69-73. doi: 10.1089/obe.2007.0019. PMID: 20436797; PMCID: PMC2861983.
9. Gill H, Tiwari P, Dabadghao P. Prevalence of polycystic ovary syndrome in young women from North India: A Community-based study. Indian J Endocrinol Metab. 2012 Dec;16(Suppl 2):S389-92. doi: 10.4103/2230-8210.104104. Erratum in: Indian J Endocrinol Metab. 2013 Jan;17(1):162. PMID: 23565440; PMCID: PMC3603088.
10. Khomami MB, Tehrani FR, Hashemi S, Farahmand M, Azizi F. Of PCOS symptoms, hirsutism has the most significant impact on the quality of life of Iranian women. PLoS One. 2015 Apr 15;10(4):e0123608. doi: 10.1371/journal.pone.0123608. PMID: 25874409; PMCID: PMC4398498.
